Navigation Links
Euro Shield

ProductsEuro Shield
Company Pulse Medical Inc.
Item Euro Shield
Features 
  • The lightest Pb eye protection available
  • Frame is made of flexible nylon and has large molded shielding style temples
  • Frame also features a universal form-fit bridge for maximum comfort
  • Side shields are made from solid lead sheeting
  • Color: Blue
    • Description Stylish and comfortable eye protection Properly manufactured radiation protective eyewear can eliminate approximately 90% of scatter radiation. Our high quality frames and materials offer the best protection and comfort with minimized weight. Our lenses are made of Schott RS-520 (SF-6 leaded) optics that meet all industry standards. Most Pulse Glasses are offered with lead impregnated side shielding for maximum radiation saftey.
    Info Pulse Medical Inc.
    Customer Service: (800) 342-5973
    Web site: http://www.rci-pulsemed.com

    Related medicine products :

    1. Pediatric Combination Eye Garter Shield Cover and Fox Shield
    2. Universal Eye Shield - child
    3. Universal Eye Shield - adult
    4. Universal Goffman Blue Eye Garter Shield Cover and Blue Eye Shield
    5. Combination Eye Garter Shield Cover and Fox Shield
    6. Eye Garter Shield Cover
    7. Eye Garter Shield Cover - white
    8. Fox Eye Shield - 50 per box
    9. Storz Easy Shield Adhesive Bandages
    10. Pediatric Corneal Shields 10/Box
    11. BD Visitec Eye Drains and Shields
    TAG: Euro Shield
    Straight, single action bone forceps to excise, trim and sculpt bone.
    Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps.
    CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but wi
    The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications.
    Medicine Products:
    (Date:12/3/2008)... A man-made chemical was added to the blood thinne.... 3 (HealthDay News) -- A final report on the dead...irms that the problem was caused by a man-made che...ed from China, U.S. investigators report. , The...2 adverse reactions and as many as 81 deaths in th...
    (Date:12/3/2008)... , , A Minimal 2% Growth in the Baccalaure...e Reached Enrollment Capacity , , WASHING...n Association of Colleges of Nursing (AACN) today ...llment in entry-level baccalaureate nursing progra.... Though this marks the eighth consecutive year o...
    (Date:12/3/2008)... PRINCETON, N.J., Dec. 3 /PRNewswire-USNewswire/ -...ident and CEO, New Jersey Hospital Association: ,... New Jersey hospitals will share funding from the ... That,s welcome news for those facilities, but the...ther fragile hospitals have been turned away. Whil...
    (Date:12/3/2008)... GEORGIA, Vt., Dec. 3 In response ... in this difficult economy, a nutritional expert,...rging parents to breastfeed,or use formula respon... "It is critical that parents refrain from d...e tough economic times," said Barbara S. Levine, R...
    Breaking Medicine News(10 mins):Health News:Report Confirms Source of Contaminated Heparin 2Health News:Report Confirms Source of Contaminated Heparin 3Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 2Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 3Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 4Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 5Health News:Cornell Nutritional Expert, Vermont Baby Formula Company Urge Parents Not to Dilute Formula with Extra Water 2
    ...onducted at the Howard Hughes Medical Institute an... suggests that human evolution may not be all abou...f a moment but because of interbreeding with relat...ed in the introduction of variant genes called all...
    ...ers of an event mainly depends upon whether a cert... the memory, according to researchers at UC Irvine...ll only parts of an experience such as a car accid...y recall all of the details of a similar experienc...
    ... wheat during pregnancy may lower the risk of brea...y published //in the Nov 15, 2006 issue of Interna...ena Hilanivi-Clarke from Georgetown University in ...ducted their study in rats which revealed that dau...
    ... developed by a team at Brunel University to help ... they are feeling during the course of a day. // ...ring their visits to the doctor. This program may...ires only a standard portable computer that can be...
    Other Medicine News:Health News:Strong Evidence Suggests Incidence Of Mating Of Ancestors With Neanderthals 2Health News:Memories Linked To Their Packaging In The Brain 2Health News:Risk Of Breast Cancer Lowered In Offspring Of Mothers Who Eat Whole Wheat 2Health News:Pain Tracked By 3D Computer Map 2
    (Date:12/2/2008)...east-specific gamma imaging,(BSGI) is effective i... or by,clinical exam, according to a study presen...al Society of North America (RSNA). , "BSGI...cancer-invasive,lobular carcinoma," said lead aut...and director of the Breast Imaging and Interventio...
    (Date:12/2/2008)...-- Micromet, Inc. (Nasdaq: MITI ), a biopharmace...odies for the treatment of cancer, inflammation an... entered into an agreement expanding its Committed... Capital Limited, a private investment group. Und...mitted to provide up to $75 million of capital dur...
    (Date:12/1/2008)...td today announced the initiation of a Phase 1/2 c...e JAK2 inhibitor, in leading medical centers in Au...fibrosis (CIMF). , , The trial is designed... in patients with CIMF and is expected to enrol up...ll assess the safety profile and evaluate the phar...
    (Date:12/1/2008)...stCall/ -- Genaera Corporation (Nasdaq: GENR ) ...in study MSI-1436C-102 (Study 102), the multiple a...-1436) in overweight and obese type 2 diabetics. M...f type 2 diabetes and obesity which works centrall...pathways through the highly selective inhibition o...
    Breaking Medicine Technology:New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Completely novel action of insulin unveiled 28847 1Completely novel action of insulin unveiled 28847 2Big Lottery to fund scientific research 28845 1Very cold ice films in laboratory reveal mysteries of universe 5734 1Very cold ice films in laboratory reveal mysteries of universe 5734 2Very cold ice films in laboratory reveal mysteries of universe 5734 312 outstanding young scientists named as EMBO Young Investigators 5732 112 outstanding young scientists named as EMBO Young Investigators 5732 2
    ...amp; MADISON, N.J.--(BUSINESS WIRE)--Jun 28, 2007,...nd Wyeth,Pharmaceuticals, a division of Wyeth (NYS...hree-month open-label extension study of,subcutane...nduced,constipation (OIC) in patients with advance...ed at the Multinational Association of,Supportive ...
    ...-(BUSINESS WIRE)--Jun 28, 2007 - CombinatoRx,Inco...y results of,its randomized, blinded, placebo-cont...rheumatoid arthritis (RA). The trial,compared CRx-...DMARD) to placebo plus DMARD (control) in subjects...is trial, CRx-150 demonstrated,statistically signi...
    Other Medicine Technology:Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 2Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 3Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 4Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 5Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 6CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 2CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 3CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 4CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 5